Nitin S. Damle, M.D, FACP
Internist, South County Internal Medicine, Inc.
Nitin S. Damle M.D, FACP, has been an internist in Southern Rhode Island (Wakefield) for seventeen years. He is a partner and founder of a six physician private practice (South County Internal Medicine Inc). He did his undergraduate/graduate work at the University of Michigan and medical school at Wayne State University in Detroit, Michigan. Dr. Damle completed his medical training in Internal Medicine in 1988 at Brown University Affiliated Hospitals.
Dr. Damle is Board Certified by the American Board of Internal Medicine (1988) and in 1994 became a fellow of the American College of Physicians. He is an attending physician and Immediate Past President of the Medical Staff of South County Hospital. Prior to the Presidency, he was Chief of the Department of Medicine from 1998 to 2002. He is currently a member of the Board of Trustees of South County Hospital and serves on the Medical Executive and Governance Committees of the Board. Dr. Damle is also on the Council and a member of the Public Laws Committee of the Rhode Island Medical Society. He is Council Member of the American College of Physicians, Rhode Island Chapter.
South County Internal Medicine Inc. is the largest group practice in the South County area. Dr. Damle and his partner implemented Electronic Medical Records (EMR) in 1997 and have significant experience in building an EMR and establishing interoperability with other medical sites.
Dr. Damle has done significant research and lectured on Lyme Disease over the past fifteen years, including six publications and reviews. He was a co-investigator for the large national clinical trial of Lyme vaccine (Lymerix) with Glaxo/Smith Klein from 1995 to 2000.
Dr. Damle is a consultant in Internal Medicine at the University of Rhode Island Health Service and a member of the Institutional Review Board for Human Subject Research at the university. He also writes a monthly column on various medical issues for the local community newspaper.
< return to board page
